| Date Filed | Type | Description |
| 06/09/2023 |
4
| Greene John (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 13,000 options to buy
@ $62.59, valued at
$813.7k
|
|
| 02/27/2023 |
4
| Greene John (EVP, CFO) has filed a Form 4 on Discover Financial Services|
Txns:
| Granted 9,960 shares
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Greene John (EVP, CFO) has filed a Form 4 on Discover Financial Services|
Txns:
| Paid exercise price by delivering 1,752 shares
@ $102.22, valued at
$179.1k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Greene John (EVP, CFO) has filed a Form 4 on Discover Financial Services|
Txns:
| Sold 4,443 shares
@ $127.946, valued at
$568.5k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Greene John (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 15,000 options to buy
@ $59.7, valued at
$895.5k
|
|
| 01/27/2020 |
4
| Greene John (EVP & CFO) has filed a Form 4 on Discover Financial Services|
Txns:
| Bought 3,377 shares
@ $73.8356, valued at
$249.3k
|
|
| 01/24/2020 |
4
| Greene John (EVP & CFO) has filed a Form 4 on Discover Financial Services|
Txns:
| Granted 11,198 shares
@ $0 |
|
| 09/20/2019 |
4
| Greene John (EVP & CFO) has filed a Form 4 on Discover Financial Services|
Txns:
| Granted 11,861 shares
@ $0 |
|
| 09/20/2019 |
3
| Greene John (EVP & CFO) has filed a Form 3 on Discover Financial Services |
| 06/13/2019 |
4
| Greene John (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 30,000 options to buy
@ $43.52, valued at
$1.3M
|
|
| 06/13/2019 |
3
| Greene John (Director) has filed a Form 3 on CRISPR Therapeutics AG |
| 03/08/2018 |
4
| Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,951 shares
@ $0
Disposed/sold 14,230 restricted stock units
@ $0
Disposed/sold 42,727 restricted stock units
@ $0
Disposed/sold 113,230 options to buy
@ $44.51, valued at
$5M
Disposed/sold 56,615 options to buy
@ $44.51, valued at
$2.5M
|
|
| 02/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2018 |
4
| Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 42,727 restricted stock units
@ $0 |
|
| 03/27/2017 |
4/A
| Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc. |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2016 |
3
| Greene John (EVP, CFO and Treasurer) has filed a Form 3 on Bioverativ Inc. |